← back to search

Guang‐Tao Yu

Ministry of Education of the People's Republic of China · CN
Area of research
Biomedical Engineering · Oncology
Research interest
Research interests include Cancer research, Medicine, Immunotherapy, Immune system, Tumor microenvironment, and Chemistry.
h-index
citations
2,256
works
21
NIH funding
primary concept
email

Recent publications

Robust Metformin Nanosystem Promotes Hair Growth in Androgenetic Alopecia
Research 2025cited by 4position: middledoi
Biomimetic photosynthesis nanoreactors based thylakoid synergy with metformin for reversing tumor immunosuppressive microenvironment therapy
Chemical Engineering Journal 2025cited by 1position: middledoi
A customized immunomodulator reinforces the T cell-mediated immunological cascade for cancer therapy
Chemical Engineering Journal 2025cited by 0position: middledoi
Highly BBB-permeable nanomedicine reverses neuroapoptosis and neuroinflammation to treat Alzheimer's disease
Biomaterials 2024cited by 41position: middledoi
Biomimetic MDSCs membrane coated black phosphorus nanosheets system for photothermal therapy/photodynamic therapy synergized chemotherapy of cancer
Journal of Nanobiotechnology 2024cited by 34position: lastdoi
Theoretical basis, state and challenges of living cell-based drug delivery systems
Theranostics 2024cited by 21position: lastdoi
Lymph node targeting strategy using a hydrogel sustained-release system to load effector memory T cells improves the anti-tumor efficacy of anti-PD-1
Acta Biomaterialia 2024cited by 8position: lastdoi
Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates
Science Advances 2023cited by 102position: middledoi
Microwave-responsive gadolinium metal-organic frameworks nanosystem for MRI-guided cancer thermotherapy and synergistic immunotherapy
Bioactive Materials 2023cited by 28position: lastdoi
Innovative Strategies for Hair Regrowth and Skin Visualization
Pharmaceutics 2023cited by 21position: middledoi
Biomimetic manganese-based theranostic nanoplatform for cancer multimodal imaging and twofold immunotherapy
Bioactive Materials 2022cited by 107position: lastdoi
Brain-Targeted Biomimetic Nanodecoys with Neuroprotective Effects for Precise Therapy of Parkinson’s Disease
ACS Central Science 2022cited by 71position: middledoi
“Swiss Army Knife” black phosphorus-based nanodelivery platform for synergistic antiparkinsonian therapy via remodeling the brain microenvironment
Journal of Controlled Release 2022cited by 34position: middledoi
Advanced materials and technologies for oral diseases
Science and Technology of Advanced Materials 2022cited by 32position: lastdoi
Genetically Programmable Fusion Cellular Vesicles for Cancer Immunotherapy
Angewandte Chemie International Edition 2021cited by 118position: middledoi
Cancer Cell Membrane Camouflaged Nanoparticles to Realize Starvation Therapy Together with Checkpoint Blockades for Enhancing Cancer Therapy
ACS Nano 2019cited by 340position: middledoi
Cancer Stem Cell‐Platelet Hybrid Membrane‐Coated Magnetic Nanoparticles for Enhanced Photothermal Therapy of Head and Neck Squamous Cell Carcinoma
Advanced Functional Materials 2019cited by 208position: middledoi
Cancer Cell Membrane‐Coated Nanoparticles for Personalized Therapy in Patient‐Derived Xenograft Models
Advanced Functional Materials 2019cited by 187position: middledoi
Platelet–Leukocyte Hybrid Membrane‐Coated Immunomagnetic Beads for Highly Efficient and Highly Specific Isolation of Circulating Tumor Cells
Advanced Functional Materials 2018cited by 223position: middledoi
Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma
OncoImmunology 2018cited by 65position: middledoi
STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC
Journal of Dental Research 2017cited by 196position: middledoi
LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma
OncoImmunology 2016cited by 178position: middledoi
NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell
Scientific Reports 2016cited by 96position: middledoi
CTLA4 blockade reduces immature myeloid cells in head and neck squamous cell carcinoma
OncoImmunology 2016cited by 83position: firstdoi
Targeting STAT3 signaling reduces immunosuppressive myeloid cells in head and neck squamous cell carcinoma
OncoImmunology 2016cited by 39position: middledoi
Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance
Small 2015cited by 498position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Guowang Cheng · Guangzhou University of Chinese Medicine11 papers (2022–2025)Zhi‐Jun Sun · Ministry of Education of the People's Republic of China10 papers (2015–2019)Tongkai Chen · Guangzhou University of Chinese Medicine9 papers (2022–2025) · 9 papers (2015–2024)Yuyue Zhao · Ministry of Education of the People's Republic of China9 papers (2016–2025)Lin‐Lin Bu · Huazhong Agricultural University9 papers (2015–2019)Wen‐Feng Zhang · Shandong University of Traditional Chinese Medicine8 papers (2015–2019)Yanhua Han · Guangzhou University of Chinese Medicine6 papers (2022–2024) · 6 papers (2018–2023)Ashok B. Kulkarni · National Institute of Allergy and Infectious Diseases5 papers (2016–2018)Ke‐Long Zou · Union Hospital5 papers (2022–2024)Wei Liu · City University of Hong Kong5 papers (2015–2019)Wei‐Wei Deng · Ministry of Education of the People's Republic of China5 papers (2016–2019)Hao Cui · Southern Medical University5 papers (2023–2025)Qiuying Mai · Guangzhou University of Chinese Medicine4 papers (2022–2025)Si‐Rui Ma · Ministry of Education of the People's Republic of China4 papers (2016–2018)Shishang Guo · Yangtze University4 papers (2015–2019)Liang Mao · Ministry of Education of the People's Republic of China4 papers (2016–2018)Xiaojia Chen · Jinan University4 papers (2022–2025)Xingzhong Zhao · Ministry of Education of the People's Republic of China3 papers (2015–2019)